Literature DB >> 15086531

Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.

Nianhang Chen1, Maarten E A Reith.   

Abstract

The present study addresses the effect of intracellular Na(+) and membrane potential on the binding of dopamine (DA) to the dopamine transporter (DAT). Perforation of plasma membranes of DAT-expressing cells with gramicidin diminished DA uptake and decreased the potency (increases K(i)) of DA in inhibiting the binding of cocaine analog [(3)H]2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane (CFT). It also compromised the ability of external Na(+) to reduce DA K(i). No substantial effect on DA K(i) was observed upon gramicidin treatment in Na(+)-free buffer, membrane depolarization with high [K(+)](o), or elevation of [Na(+)](i) with monensin under non-depolarizing conditions. Elevation of DA K(i) was greater at more positive potentials when [Na(+)](i) was raised to a similar level, or at higher [Na(+)](i) when the membrane was depolarized to a similar level. In cells expressing D313N DAT, DA K(i) was significantly higher but less sensitive to gramicidin than that in wild-type (WT) cells. In contrast, DA K(i) in cell-free membranes was insensitive to Na(+), gramicidin, and D313N mutation. The data suggest that (i) intracellular Na(+) plays a role in affecting the external access to DA binding sites at DAT on depolarized plasma membranes of cells, and (ii) access to DA binding sites in cell-free membranes may occur from the intracellular side of the membrane. Unlike DA binding, CFT binding to both cells and membranes was sensitive to Na(+) and D313N mutation but insensitive to gramicidin, consistent with exclusively external access to sites that are different from but conformationally linked to those for DA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086531     DOI: 10.1111/j.1471-4159.2004.02409.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities.

Authors:  Juan Zhen; Tamara Antonio; Shu-Yuan Cheng; Solav Ali; Kymry T Jones; Maarten E A Reith
Journal:  J Neurochem       Date:  2015-01-26       Impact factor: 5.372

2.  Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.

Authors:  Mark J Ferris; Erin S Calipari; Yolanda Mateo; James R Melchior; David C S Roberts; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

Review 3.  Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.

Authors:  Pedro A Jose; Patricio Soares-da-Silva; Gilbert M Eisner; Robin A Felder
Journal:  Biochim Biophys Acta       Date:  2010-02-12

4.  Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters.

Authors:  Ying-Jian Liang; Juan Zhen; Nianhang Chen; Maarten E A Reith
Journal:  J Neurochem       Date:  2009-03-11       Impact factor: 5.372

5.  Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change.

Authors:  Gianluigi Tanda; Su Min Li; Maddalena Mereu; Alexandra M Thomas; Aaron L Ebbs; Lauren E Chun; Valeria Tronci; Jennifer L Green; Mu-Fa Zou; Theresa A Kopajtic; Amy Hauck Newman; Jonathan L Katz
Journal:  Psychopharmacology (Berl)       Date:  2013-04-24       Impact factor: 4.530

6.  Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.

Authors:  Kyle C Schmitt; Juan Zhen; Prashant Kharkar; Manoj Mishra; Nianhang Chen; Aloke K Dutta; Maarten E A Reith
Journal:  J Neurochem       Date:  2008-09-11       Impact factor: 5.372

7.  Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.

Authors:  Rejwi Acharya Dahal; Akula Bala Pramod; Babita Sharma; Danielle Krout; James D Foster; Joo Hwan Cha; Jianjing Cao; Amy Hauck Newman; John R Lever; Roxanne A Vaughan; L Keith Henry
Journal:  J Biol Chem       Date:  2014-08-31       Impact factor: 5.157

8.  Anomalous dopamine release associated with a human dopamine transporter coding variant.

Authors:  Michelle S Mazei-Robison; Erica Bowton; Marion Holy; Martin Schmudermaier; Michael Freissmuth; Harald H Sitte; Aurelio Galli; Randy D Blakely
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

Review 9.  Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.

Authors:  Caline S Karam; Jonathan A Javitch
Journal:  Adv Pharmacol       Date:  2017-10-25

10.  Importance of cholesterol in dopamine transporter function.

Authors:  Kymry T Jones; Juan Zhen; Maarten E A Reith
Journal:  J Neurochem       Date:  2012-10-11       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.